Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lien Davidson, a 2nd year DPhil student in the Coward Group, won the Medical Sciences Divisional heat and was then runner up in the University final in a recent 3-minute thesis competition.

Lien Davidson is a DPhil student at the Nuffield Department of Obstetrics & Gynaecology exploring the use of infra-red lasers as an investigative tool for developmental biology and early stage embryos © Nuffield Department of Obstetrics & Gynaecology
Lien Davidson is a DPhil student at the Nuffield Department of Obstetrics & Gynaecology exploring the use of infra-red lasers as an investigative tool for developmental biology and early stage embryos

Summing up your entire doctorate in three minutes is a challenge. That's about 400 - 500 words, compared to the 80,000 word limit for a doctoral thesis. Yet, that's the challenge of the 3 Minute Thesis (3MT), a competition originally developed by The University of Queensland. It aims to cultivate students' academic, presentation, and research communication skills. The competition supports their capacity to effectively explain their research in three minutes, in a language appropriate to a non-specialist audience.

Below, you'll find the 3 Minute Thesis of Lien Davidson, a DPhil candidate, part of the Coward Group in the Institute of Reproductive Sciences, Nuffield Department of Obstetrics and Gynaecology. 

Lien Davidson
Some of you may have heard of the name Louise Brown, she was the first test tube baby, or in vitro fertilisation baby, and she was born right here in the UK. What some of you might not know is that in vitro fertilisation, or IVF, isn't only for couples who are infertile.

But why would a fertile couple want to go through the complicated and expensive procedure of IVF? Well the answer to that question is: hereditary genetic disease. A couple with a genetic disease is able to use IVF to produce genetically healthy children.

This is done through a process called 'Embryo biopsy'. You take a sperm from the man, an egg from the woman, and you fertilise them together in the lab to create an embryo. This embryo divides into 2 cells, 4 cells, 8 cells, and so on, and at this early stage every single cell in the embryo is perfectly identical. What we know as scientists is that at this early stage, you can remove one of these cells from the embryo and the rest will continue to grow on healthily. And with this one cell you can test the entire genome of that whole embryo. That way, you can choose an embryo that's free of the genetic disease, and place that one back into the mother's uterus.

So, how do you get this cell out for testing? It's an extremely delicate and fragile procedure, because embryos at this stage have a protective shell around them, much like that of a chicken's egg, and this needs to be breached. Currently in clinics this can be done by drilling a small hole using a laser pulse, and that's where my research comes in, I research the safety of these lasers on embryos.

Embryo biopsy has been performed all over the world and healthy babies have been born, but how safe is this technique really at the time the hole is being drilled? There's no standardisation or detailed safety investigations of how the hole should be created, and every clinic does it differently.

So to investigate the safety of these lasers on embryos I use a mouse model, which looks and grows the same way as a human embryo in these early days. I'm testing different holes sizes, laser powers, and hole locations in the shell to see if there are any damaging effects that we might not know about yet. Results so far at the halfway point of my thesis have found there are certain laser treatments which appear safe for use in the embryos, and others which appear damaging in terms of the quality of the DNA and the embryo's metabolism. I’m currently looking to see if there are any minor changes in important developmental genes which could be having negative effects.

My goal for the future is to find safe laser parameters for standardisation in the clinic, and to highlight other damaging parameters that should be avoided altogether. Given that these procedures are used to literally create healthy life, the safety of each step is of the utmost importance, and with the continuation of studies such as these, we can have the peace of mind of knowing that these techniques are not damaging the precious lives that are being created.

Similar stories

MitOX 2023- 21st April

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2023 on Friday 21st April. Our annual conference for researchers with an interest in mitochondria from academia and pharma. This year's event will be 'hybrid', so you can join in-person or virtually!

Award Winning Podcast

‘Unheard of – The hidden voice of Endometriosis ’ the podcast series co-hosted by Danielle Perro (Postdoctoral Researcher in Epidemiology) and Magda Mareckova (DPhil student) has been recognised by the Wellcome Centre for Human Genetics, with a Public Engagement with Research Project Award.

What is the impact of heavy menstrual bleeding on female health and well-being?

Many of us have no idea whether or not our period is “normal”. It’s no wonder, since not only is everyone different, but the stigma still keeps many of us from asking questions or discussing what we go through every month with friends and family. Principal Investigator Prof Suzannah Williams and DPhil student Tomi Adeniran explore what heavy periods can mean in their article published in The Conversation.

Women's Health Strategy for England Launched

The government has published the first ever Women's Health Strategy for England to tackle the gender health gap. Menopause, Endometriosis, Contraception and Fertility treatment are highlighted as some of the top issues women have asked for action on. The Nuffield Department of Women's & Reproductive Health welcome and fully support this bold and exciting strategy to help improve the health of millions of women in England.

Prof Christian Becker wins Clinical Science Award at ESHRE 2022

Congratulations to Professor Christian Becker who was presented with a Clinical Science Award for best oral presentation at the ESHRE 38th Annual Meeting in Milan, Italy this week.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.